Artificial Intelligence is revolutionizing India's pharmaceutical landscape, transforming the nation from the traditional "pharmacy of the world" into the "intelligent pharmacy of the world." This technological shift is reshaping drug discovery, regulatory processes, and supply chain management across the industry.
Hari Kiran Chereddi, MD & CEO of HRV Pharma & New Horizon Global Pharma, shared insights on this transformation during a recent industry discussion, highlighting how AI is becoming the productive engine driving pharma's future.
The AI Revolution in Numbers:
- Regulatory Filing Speed: Compressed from over a year to just months
- Productivity Boost: 30-40% improvement expected across operations
- Market Growth: AI in drug discovery set to grow at 33% CAGR through 2030
From Reactive to Predictive Healthcare
The transformation extends beyond drug discovery into comprehensive value chain optimization. AI-powered systems now enable predictive quality control, advanced supply chain orchestration, and accelerated regulatory compliance.
"As everyone is fixated on AI in drug discovery, we at HRV Pharma are proving its influence across the value chain — from compliance to supply to development. Through AI, we've moved from a reactive to a predictive approach. Our systems scan data across quality issues across partner plants, flagging risks before regulators ever do."
Hari Kiran Chereddi, MD & CEO of HRV Pharma & New Horizon Global Pharma
Strategic Impact Areas:
- Drug Discovery: AI screens millions of molecules, reducing timelines by up to 60%
- Regulatory Excellence: GenAI reduces medical writing time by over 50%
- Supply Chain Resilience: Predictive orchestration ensures continuity during disruptions
- Specialized Therapeutics: Focus on orphan diseases, oncology, and animal health
India's Intelligent Pharma Vision
The industry's evolution aligns with India's broader healthcare ambitions. With the pharmaceutical sector projected to reach $120-130 billion by 2030, AI integration represents both operational excellence and strategic positioning for global leadership.
"To us, AI is not a buzzword but a productive engine of change. India has been known as the 'pharmacy of the world' for years. With AI leading us, we believe it can now be the intelligent pharmacy of the world — delivering safer, smarter, and more affordable drugs to those who need them most."
Hari Kiran Chereddi, MD & CEO of HRV Pharma & New Horizon Global Pharma
Industry Adoption and Impact
Current adoption patterns demonstrate significant momentum, with 50% of Indian pharma companies investing in AI technologies and 25% already deploying GenAI in production environments. This technological integration is yielding measurable benefits across operational efficiency, regulatory compliance, and innovative therapeutic development.
The Path Forward
AI's role in pharmaceutical transformation extends beyond automation to enable breakthrough innovations in underserved therapeutic areas. By combining India's established manufacturing expertise with advanced AI capabilities, the industry is positioned to address global healthcare challenges while maintaining cost-effectiveness and quality standards.
The transition to an "intelligent pharmacy" model represents more than technological advancement—it's a strategic evolution that positions India as a leader in next-generation pharmaceutical innovation and global health solutions.
Read the complete coverage: How AI is Turning India from 'Pharmacy of the World' into 'Intelligent Pharmacy of the World' - Mathrubhumi English
